Search
for
Sort by
Research 211–240 of 324
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Insights into the role of grooming modifications and preventative approaches in Pseudofolliculitis barbae: A narrative review of hair removal practices
- Human Liver MSCs Retain Their Basic Cellular Properties in Chronically Inflamed Liver Tissue
- Circulating monocytes as a marker of response to adalimumab in patients with hidradenitis suppurativa: A single institution, real-world cohort study
- A retrospective clinical and laboratory analysis including vitamin D and antinuclear antibodies in central centrifugal cicatricial alopecia and nonscarring alopecia in African Americans
- Clinical features of hidradenitis suppurativa among elderly: Insights from a large multicenter tertiary cohort
- Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies
- The prevalence of skin diseases in Greece, impact on quality of life and stigmatization: A population‐based survey study
- Effectiveness and Safety of Resilient Hyaluronic Acid (RHA) Dermal Fillers for the Correction of Moderate-to-Severe Nasolabial Folds in People of Color: Post Hoc Subgroup Analyses of US Pivotal Clinical Data
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Clinical Efficacy of Topical or Oral Soy Supplementation in Dermatology: A Systematic Review
- The COVID-19 pandemic and its skin effects
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Universal Dermatology: Bridging Gaps in Skin Health
- Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in Australia
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- Assessment of Alopecia Areata Disease Severity in Pediatric Patients
- Patient preferences in the treatment of alopecia areata: A review of the literature
- Efficacy of baricitinib in treatment of coexisting alopecia areata and lichen planopilaris
- Adult patients with alopecia areata report a significantly better medication adherence compared to those with atopic dermatitis: Results from a large cross-sectional cohort study
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm
- Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: e-Posters
- Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review